-
News | 2021.07.19
AFROSCREEN, boosting variant surveillance in 13 African countries
The Agence française de développement (AFD) and ANRS | Maladies infectieuses émergentes, in partnership with the Institut Pasteur, IRD, and laboratories across 13 African countries, are launching the joint AFROSCREEN project. This project meets an urgent need for surveillance of the development of SARS-CoV-2 variants and other emerging pathogens by bolstering laboratory genomic sequencing...
-
News | 2023.03.22
The origins of SARS-CoV-2: the search goes on
Where did SARS-CoV-2 come from? How did this virus enter the human population? These questions still remain unanswered. In June 2022, a group of experts, the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) commissioned by the World Health Organization (WHO), published a report on the origin of coronavirus but was unable to draw a definitive conclusion. Since then, research has...
-
Document de presse | 2020.04.24
Development and evaluation of four serological assays to detect SARS-CoV-2 antibodies and two assays to detect neutralizing antibodies
Approximately four months after the initial description of cases of atypical pneumonia in Wuhan, China, in December 2019, COVID-19 had become a major pandemic threat. By April 12, 2020, around half of the world's population was in lockdown, with 1.8 million officially diagnosed cases. Scientists from the Institut Pasteur, the CNRS, Inserm and Université de Paris conducted a pilot study to...
-
Document de presse | 2020.05.26
MV-SARS-CoV-2 vaccine candidate: a new partnership between Institut Pasteur, CEPI, Thémis and MSD
Institut Pasteur announces recent advances in the development of one of its candidate vaccines, MV-SARS-CoV-2, using the measles vector, as part of a renewed partnership with CEPI and the companies Thémis and MSD.With over 100 vaccine projects in development worldwide, the development of a vaccine against SARS CoV-2 infection remains a challenge, with many scientific uncertainties ahead. The...
-
Article | 2022.05.30
Afroscreen Project : boosting variant surveillance in 13 african countries
The Agence française de développement (AFD) and ANRS | Maladies infectieuses émergentes, in partnership with the Institut Pasteur, IRD, and laboratories across 13 African countries, are launching the joint AFROSCREEN project. This project meets an urgent need for surveillance of the development of SARS-CoV-2 variants and other emerging pathogens by bolstering laboratory genomic sequencing...
-
Document de presse | 2020.11.16
Operation and reliability of RT-PCR tests in the detection of SARS-CoV-2
The National Reference Center (CNR) for Respiratory Viruses at the Institut Pasteur specializes in viruses such as influenza and bronchiolitis in infants. As an expert center in France, the CNR is responsible for monitoring cases of respiratory infections and for epidemic surveillance. When a new virus emerges, like the novel coronavirus in China, the CNR's task is to do everything it can to...
-
Document de presse | 2020.05.29
A preclinical study shows that hydroxychloroquine has no antiviral effect on SARS-CoV-2 in vivo
A study on the effects of hydroxychloroquine n macaques infected with the SARS-CoV-2 virus, used alone or in combination with azithromycin, have been pre-published(1) on Research Square, after their submission to Nature. Scientists from the CEA, Inserm, Institut Pasteur, Université de Paris-Saclay, Université Claude Bernard Lyon 1 and Aix-Marseille Université have been involved in the study...
-
News | 2021.09.30
DIM ELICIT Symposium on Wednesday, October 20, 2021 at IPGG: registrations are open!
The DIM ELICIT (Empowering LIfe sCiences with Innovative Technologies) is organizing its closing event on Wednesday, October 20, 2021 at the Pierre-Gilles-de-Gennes Institute for Microfluidics (IPGG). The program will highlight the most emblematic projects of the DIM ELICIT with interventions in the form of pairs (biologist/technologist). This will be also an opportunity to exchange with the...
-
Article | 2016.12.20
Cell Biology and Infection
The work of the Department of Cell Biology and Infection is focused on elucidating the workings of cells – the basic building blocks of all living beings –, to gain a greater understanding of how they behave in the presence of microbes or diseases such as cancer and neurodegenerative disorders. The teams in the research department pursue an integrative approach that combines expertise in...
-
Événement | 2022.12.02
Epidemic, pandemic... Infodemic: the other health emergency
The symposium called "Epidemic, pandemic... Infodemic: the other health emergency", organized by Université Paris Cité and the Institut Pasteur, will be held on December 2, 2022. This event will take place at the Institut Pasteur (Paris, 15th arrondissement), in French. Registration is free but mandatory.(This event will be held in French)Les questions de communication et d’information...
